BAM
GSK icon

Bruderman Asset Management’s GSK GSK Stock Holding History

Bruderman Asset Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-6,372
Closed -$354K – 103
2019
Q3 		$354K Sell
6,372
-533
-8% -$27.4K 0.09% 95
2019
Q2 		$345K Sell
6,905
-2,400
-26% -$120K 0.08% 88
2019
Q1 		$486K Sell
9,305
-635
-6% -$31.7K 0.11% 95
2018
Q4 		$475K Sell
9,940
-2,203
-18% -$108K 0.12% 87
2018
Q3 		$610K Sell
12,143
-123,935
-91% -$6.3M 0.14% 85
2018
Q2 		$6.86M Sell
136,078
-71,916
-35% -$3.62M 1.67% 15
2018
Q1 		$10.2M Buy
207,994
+51,399
+33% +$2.39M 2.43% 13
2017
Q4 		$6.94M Sell
156,595
-97,567
-38% -$4.51M 1.76% 18
2017
Q3 		$12.9M Buy
254,162
+5,964
+2% +$303K 3.34% 8
2017
Q2 		$13.4M Buy
248,198
+58,411
+31% +$3.11M 3.57% 6
2017
Q1 		$10M Buy
189,787
+76,544
+68% +$3.88M 2.89% 12
2016
Q4 		$5.45M Buy
113,243
+7,708
+7% +$381K 1.64% 21
2016
Q3 		$5.69M Buy
105,535
+52,042
+97% +$2.85M 1.7% 19
2016
Q2 		$2.9M Buy
+53,493
New +$2.82M 0.91% 31
2015
Q3 		– Sell
-94
Closed -$5K – 434
2015
Q2 		$5K Sell
94
-906
-91% -$51K ﹤0.01% 390
2015
Q1 		$58K Buy
+1,000
New +$57.3K 0.02% 197

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Bruderman Asset Management's GSK Position: Q4 2019 in Review

Bruderman Asset Management sold out of GSK (GSK) in Q4 2019, closing a stake of 6,372 shares — an estimated $354K sold.

Bruderman Asset Management first reported a position in GSK in Q1 2015 and held it in 16 quarters. The position peaked at $13.4M in Q2 2017. 894 funds tracked by Wall St. Rank hold GSK as of Q4 2019.

  • Bruderman Asset Management reported no remaining GSK position as of Q4 2019 after selling out during the quarter.
  • Bruderman Asset Management sold 6,372 GSK shares in Q4 2019, an estimated $354K.
  • Bruderman Asset Management first reported a position in GSK in Q1 2015 and held it in 16 quarters.
  • Bruderman Asset Management's GSK position peaked at $13.4M in Q2 2017.
  • 894 funds tracked by Wall St. Rank held GSK as of Q4 2019.

Based on Bruderman Asset Management's 13F filing for Q4 2019, filed 13 Feb 2020.